New diabetes combo pill aims to tame blood sugar in tough cases
NCT ID NCT07239440
First seen Nov 20, 2025 · Last updated Apr 29, 2026 · Updated 18 times
Summary
This study tests a new medicine called DA-2811 for people with type 2 diabetes whose blood sugar is not well controlled with their current two-drug combination. About 288 adults will either add DA-2811 or a placebo to their existing treatment. The goal is to see if the new drug helps lower blood sugar more safely and effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Samsung Medical Center
Seoul, South Korea
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.